BioCrea Announces Upcoming Presentations At Leading International Conferences

"On target with rapid acting antidepressants" Radebeul, Germany, September 24, 2014 - BioCrea GmbH , the first-in-class CNS drug discovery specialist, today announced that Chief Executive Officer, Dr. Tom Kronbach, will present at the following three international life sciences conferences over the coming months.

http://ift.tt/1xiXtTJ